Videos & Documents
Historically, pulmonary embolism carries significant morbidity and mortality. The Pulmonary Embolism Response Team (PERT) provides a multidisciplinary approach and a “one phone call” solution for the treatment and management of pulmonary embolism.
Van-Khue Ton, MD, PhD, discusses varying types of left ventricular assist devices (LVADs) as well as best practices for implantation and the importance of timely referral for consideration of placement and heart transplant.
The multidisciplinary University of Maryland Center for Aortic Disease has a growing reputation for excellence in the evaluation and treatment of chronic aortic disease and acute aortic emergencies.
Morphologic abnormalities of the mitral valve are very common among patients with indications for operative treatment for hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction.
The University of Maryland Medical Center multidisciplinary team of adult and pediatric cardiologists, cardiac surgeons, electrophysiologists, and other specialists provide personalized care for adults and children with congenital heart problems.
Led by Bartley P. Griffith, MD was among the first in the country to implant a new resilient bovine pericardial valve with anti-calcification properties for early aortic valve replacement patients.
James S. Gammie, MD discusses a new study that found the Harpoon Mitral Valve Repair System (H-MVRS), a novel investigational device, was safe and effective in treatment of degenerative MR, the most common type of heart valve disorder.
Medical researchers have begun testing to see whether adult stem cells derived from bone marrow benefit children with the congenital heart defect hypoplastic left heart syndrome (HLHS).
In the US, approximately 1,000 babies per year are born with hypoplastic left heart syndrome and currently have a mortality rate of about 33% within the first year of life.
Dr. Shahab Toursavadkohi of University of Maryland presents surgical therapies and practices for treating massive Pulmonary Embolisms in patients.
With advances in Pediatric Heart Surgery and increased survival rate, the adult population for Congenital Heart Disease has created a demand speciality for Cardiologists.
Pediatric cardiologist Carissa Baker-Smith, MD and lead author on new American Academy of Pediatrics guidelines for diagnosing and treating high blood pressure in children discusses what providers should know about the new guidelines.
James Gammie, MD, Chief of Cardiac Surgery and mitral valve disease specialist, discusses basic principles and best practices associated with repair of the degenerative mitral valve.
Vincent See, MD, electrophysiologist, as well as Murtaza Dawood, MD, cardiac surgeon, discuss how procedures like the WatchmanTM device implantation are helping to prevent stroke in afib patients.
A 78-year-old woman with atrial fibrillation recently came to the University of Maryland Medical Center in deep fear: The blood thinner she was taking to avoid a stroke — which may occur from <2% up to 20% of untreated atrial fibrillation (AF) patients
University of Maryland Medical Center vascular surgeon Dr. Shahab Toursavadkohi, Dr. Tour for short, talks you through EVAR Surgery, a minimally-invasive procedure to repair aneurysms.
Brad Taylor, MD, cardiac surgeon and coronary revascularization specialist, discusses robotic MIDCAB procedure.
The University of Maryland Medical Center's Mechanical Heart Support Program, also known as the Ventricular Assist Device (VAD) Program, is just one of a spectrum of treatment options offered for heart patients at the University of Maryland.
The promise of individualized medicine — where tests and therapies are tailored to each patient’s precise genetic makeup — is becoming a reality for cardiology patients at the University of Maryland Medical Center (UMMC), the culmination of efforts
All cases of heart failure aren’t created equal, but University of Maryland Medical Center (UMMC) is taking part in an international clinical trial to determine if an investigational drug can slow the progression of one of the most uncommon types of this
Splitting open a patient’s chest wall and stopping the heart — part of well-established traditional coronary artery bypass surgery — are avoided in a novel robotic-assisted surgical approach used at University of Maryland Medical Center (UMMC), dramatical
University of Maryland Medical Center’s urban location means clinical teams care for some patients with a history of drug abuse — a key risk factor in a rare and dangerous form of heart valve infection.